Impact Factor
3.64
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.64
422 total citations
h5-index
30
h5 depth signal
Cited share
77.3%
75 of 97
Total citations
422
Citation footprint
Metric signal
4.10
External metric anchor
Self-citation
3.8%
16 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
88
United Kingdom
82
China
75
Germany
71
Canada
43
Citing Fields of Research
Oncology
132
Liver & Colon Cancer
58
Breast Cancer
58
Immunology
56
Cancer & Development
44
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
509
Articles tracked across the journal lifetime
Indexed publication set
97
75 cited publications
Last 12 months
64
5.3 publications/month
Open access share
100.0%
64 OA publications in the last year
Leading citing country
United States
88 citing publications
Leading citing field
Oncology
132 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Jan. 2018-
v1n1, 2015-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Liver & Colon Cancer
Urology
Immunology
Reproductive Health
Issuing & Sponsoring Bodies
issuing body
Pathological Society of Great Britain and Ireland
Broad Categories
Pathology
Digestive Disorders
Urology
Breast Cancer
Lung Cancer
Liver & Colon Cancer
Immunology
DNA Damage
MeSH Descriptors
Clinical Laboratory Techniques
Clinical Trials as Topic
Pathology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/2056-4538.70116
Open DOI
PRAME predicting outcome in uveal melanoma
Uveal melanoma (UM) is the most common primary intra‐ocular malignancy in adults and carries a high risk of metastatic disease, affecting approximately 50% of patients despite advances in local tumour control. PRAME (PReferentially expre...
02
DOI 10.1002/2056-4538.70119
Open DOI
An X‐ray micro‐ CT protocol enables non‐destructive 3D visualization of glandular architecture in archived paraffin‐embedded prostate cancer tissue
The prostate is organized as a complex glandular network, and prostate cancer is accompanied by architectural changes that cannot always be inferred from two‐dimensional (2D) histology. The study of these features in three dimensions (3D...
03
DOI 10.1002/2056-4538.70117
Open DOI
The molecular landscape of nodular fasciitis: novel USP6 fusions, genomic stability, and an exploratory clinicopathological model – a 20‐year retrospective study
Nodular fasciitis (NF) is a benign myofibroblastic neoplasm characterized by rapid growth and recurrent USP6 rearrangements. Despite its benign nature, NF may exhibit worrisome histologic or clinical features that mimic sarcoma, posing d...
04
DOI 10.1002/2056-4538.70098
Open DOI
Issue Information
05
DOI 10.1002/2056-4538.70114
Open DOI
Assessment methods of pathological complete response in neoadjuvant head and neck cancer clinical trials: a scoping review
Head and neck cancer (HNC) trials have demonstrated pathological complete response (pCR) in patients receiving neoadjuvant treatment prior to surgery; however, systematic reviews have reported marked variation in pCR rates. This scoping ...
06
DOI 10.1002/2056-4538.70118
Open DOI
Profiling EGFR , c‐ MET , and B7H3 co‐expression to guide next‐generation dual‐drug conjugate strategies in colorectal cancer
Epidermal growth factor receptor (EGFR), cellular mesenchymal‐epithelial transition factor (c‐MET), and B7 homolog 3 (B7H3) are important targets for antibody‐based drug development in colorectal cancer (CRC). To overcome the limitations...
07
DOI 10.1002/2056-4538.70113
Open DOI
Artificial intelligence‐assisted histopathological diagnosis of endocervical gastric‐type adenocarcinoma: a multicenter model development and validation study
Endocervical gastric‐type adenocarcinoma (GAS) is one of the most aggressive subtypes of cervical cancer and is frequently underdiagnosed due to morphological ambiguity, leading to delayed diagnosis. Despite the availability of molecular...
08
DOI 10.1002/2056-4538.70112
Open DOI
Increased CCR5 expression in lymphoma cells and M2 macrophages is associated with poor prognosis in primary intestinal diffuse large B‐cell lymphoma
Few studies have evaluated the impact of organ‐specific tumor microenvironments (TMEs) on clinical outcomes in diffuse large B‐cell lymphoma (DLBCL). This study investigated potential molecular markers, the immune cell composition within...
09
DOI 10.1002/2056-4538.70107
Open DOI
Genomic profiling of Mexican patients with B‐cell precursor acute lymphoblastic leukemia reveals clinically significant somatic and potential germline variants
B‐cell precursor acute lymphoblastic leukemia (preB‐ALL) is characterized by pathogenic variants currently used in precision oncology. However, the mutational landscape of Mexican children with preB‐ALL has not yet been thoroughly explor...
10
DOI 10.1002/2056-4538.70097
Open DOI
Issue Information
Bibliographical & Catalog Notes
Month and year taken from contents page.
Some articles in Volume 1 published electronically in 2014.
Early articles, June 2014-<August 2014>, published under previous title The clinical journal of pathology, and re-published in first issue of The journal of pathology. Clinical research.